Synthace Limited (07652459)
- Status
- administration
- Incorporated
- 2011-05-31
- Registered office
- C/O Restructuring Department S&W Partners Llp 45, Gresham Street, London, EC2V 7BG
- Industry
- 72110 Research and experimental development on biotechnology
Profit and loss
| Line item | 2016-05-31 | 2017-05-31 | 2018-05-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|
| Revenue / turnover | – | – | – | – | – | 648,766 | 1,343,119 | – | – | – |
|---|
| Gross profit | – | – | – | – | – | -304,995 | 401,040 | – | – | – |
|---|
| Operating profit | – | – | – | – | – | -11,092,730 | -10,178,419 | – | – | – |
|---|
| Profit before tax | – | – | – | – | – | -11,090,397 | -10,421,683 | – | -11,614,207 | -10,284,161 |
|---|
| Tax charge / (credit) | – | – | – | – | – | -1,589,019 | -1,554,713 | -1,541,973 | 106,114 | -934,779 |
|---|
| Profit after tax | – | – | – | -3,596,789 | -9,014,990 | -9,501,378 | -8,866,970 | -9,450,382 | -11,720,321 | -9,349,382 |
|---|
Balance sheet
| Line item | 2016-05-31 | 2017-05-31 | 2018-05-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|
| Total fixed / non-current assets | 265,551 | 186,827 | 235,726 | 1,197,385 | 1,427,455 | 1,064,497 | 717,206 | 555,840 | 492,506 | 272,788 |
|---|
| Current assets | 646,766 | 883,223 | 5,806,061 | 22,984,455 | 14,244,871 | 5,404,300 | – | – | – | – |
|---|
| Cash at bank | 245,002 | 224,346 | 4,912,132 | 21,062,737 | 11,671,610 | 3,303,566 | 19,211,175 | 10,824,153 | 3,998,475 | 439,512 |
|---|
| Creditors < 1 year (current liabilities) | 182,972 | 1,759,027 | 938,831 | 1,293,844 | 1,378,121 | 1,585,541 | – | – | – | – |
|---|
| Net current assets | 463,794 | -875,804 | 4,867,230 | 21,690,611 | 12,866,750 | 3,818,759 | – | – | – | – |
|---|
| Creditors > 1 year (non-current liabilities) | – | – | – | 269,860 | – | – | – | – | – | – |
|---|
| Net assets | 729,345 | -688,977 | 5,102,955 | 22,618,136 | 13,936,438 | 4,510,104 | – | 10,731,641 | 50,794 | -8,336,591 |
|---|
| Total equity | 729,345 | -688,977 | 5,102,956 | 22,618,136 | 13,936,438 | 4,510,104 | – | 10,731,641 | 50,794 | -8,336,591 |
|---|
Ratios
| Ratio | 2016-05-31 | 2017-05-31 | 2018-05-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|
| Revenue growth | – | – | – | – | – | – | 107.0% | – | – | – |
|---|
| Gross margin | – | – | – | – | – | -47.0% | 29.9% | – | – | – |
|---|
| Operating margin | – | – | – | – | – | -1709.8% | -757.8% | – | – | – |
|---|
| Net margin | – | – | – | – | – | -1464.5% | -660.2% | – | – | – |
|---|
| Return on equity | – | – | – | -38.9% | -49.3% | -103.0% | – | -88.1% | -217.4% | – |
|---|
| Return on capital employed | – | – | – | – | – | -227.2% | – | – | – | – |
|---|
| Return on invested capital (ROIC) | – | – | – | – | – | -517.7% | – | – | – | – |
|---|
| Current ratio | 3.53× | 0.50× | 6.18× | 17.76× | 10.34× | 3.41× | – | – | – | – |
|---|
Markdown version · CSV · Companies House register
